Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trypanosoma brucei brucei | 6 | 2019 | 20 | 3.100 |
Why?
|
| Fluorescence Resonance Energy Transfer | 10 | 2018 | 45 | 2.030 |
Why?
|
| Microbodies | 4 | 2018 | 60 | 1.710 |
Why?
|
| Antigens, Bacterial | 10 | 2017 | 54 | 1.550 |
Why?
|
| Flow Cytometry | 5 | 2018 | 489 | 1.500 |
Why?
|
| Receptors, Peptide | 7 | 2022 | 32 | 1.420 |
Why?
|
| Glucose | 4 | 2019 | 307 | 1.410 |
Why?
|
| Polymers | 6 | 2014 | 244 | 1.240 |
Why?
|
| Microscopy, Fluorescence | 8 | 2019 | 261 | 1.170 |
Why?
|
| Bacterial Toxins | 8 | 2017 | 50 | 1.140 |
Why?
|
| High-Throughput Screening Assays | 3 | 2018 | 48 | 1.080 |
Why?
|
| Fluorescent Dyes | 8 | 2012 | 191 | 0.930 |
Why?
|
| Polyethylene Glycols | 3 | 2014 | 149 | 0.880 |
Why?
|
| Macrophages | 7 | 2014 | 647 | 0.850 |
Why?
|
| Fluorenes | 2 | 2012 | 19 | 0.830 |
Why?
|
| Peptide Fragments | 2 | 2020 | 483 | 0.830 |
Why?
|
| Trypanocidal Agents | 2 | 2018 | 11 | 0.750 |
Why?
|
| Collagen Type IV | 1 | 2020 | 28 | 0.730 |
Why?
|
| Nanoparticles | 4 | 2012 | 254 | 0.730 |
Why?
|
| Endocytosis | 1 | 2020 | 113 | 0.710 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2019 | 18 | 0.680 |
Why?
|
| Life Cycle Stages | 1 | 2018 | 7 | 0.660 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 20 | 0.660 |
Why?
|
| Hydrogen-Ion Concentration | 7 | 2017 | 618 | 0.660 |
Why?
|
| Membrane Proteins | 3 | 2012 | 617 | 0.610 |
Why?
|
| Lysosomes | 3 | 2011 | 136 | 0.580 |
Why?
|
| Fluorescence | 4 | 2012 | 104 | 0.520 |
Why?
|
| Quantum Dots | 2 | 2012 | 29 | 0.520 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2019 | 64 | 0.460 |
Why?
|
| Protein Binding | 9 | 2021 | 1027 | 0.450 |
Why?
|
| Lipids | 2 | 2014 | 298 | 0.450 |
Why?
|
| Animals | 23 | 2022 | 20877 | 0.440 |
Why?
|
| Mice | 18 | 2022 | 8472 | 0.410 |
Why?
|
| Isoquinolines | 1 | 2011 | 37 | 0.390 |
Why?
|
| Endosomes | 1 | 2011 | 45 | 0.390 |
Why?
|
| Molecular Imaging | 1 | 2010 | 45 | 0.370 |
Why?
|
| Bacillus anthracis | 4 | 2013 | 11 | 0.370 |
Why?
|
| Macrolides | 2 | 2017 | 48 | 0.360 |
Why?
|
| Nanostructures | 1 | 2010 | 112 | 0.360 |
Why?
|
| Water | 1 | 2011 | 228 | 0.350 |
Why?
|
| Endothelial Cells | 4 | 2022 | 384 | 0.350 |
Why?
|
| Biosensing Techniques | 3 | 2018 | 51 | 0.340 |
Why?
|
| Protein Domains | 2 | 2020 | 74 | 0.330 |
Why?
|
| Calcium | 3 | 2017 | 929 | 0.320 |
Why?
|
| Protozoan Proteins | 2 | 2018 | 25 | 0.310 |
Why?
|
| Neovascularization, Pathologic | 3 | 2022 | 183 | 0.310 |
Why?
|
| Cytosol | 2 | 2018 | 123 | 0.310 |
Why?
|
| Optics and Photonics | 2 | 2021 | 29 | 0.290 |
Why?
|
| Receptors, Cell Surface | 4 | 2017 | 248 | 0.290 |
Why?
|
| Hydrolyzable Tannins | 2 | 2019 | 25 | 0.280 |
Why?
|
| Kinetics | 7 | 2012 | 1047 | 0.280 |
Why?
|
| Small Molecule Libraries | 2 | 2018 | 53 | 0.260 |
Why?
|
| Spectrum Analysis, Raman | 3 | 2012 | 38 | 0.250 |
Why?
|
| Neoplasm Proteins | 3 | 2017 | 307 | 0.240 |
Why?
|
| Cell Line | 7 | 2014 | 1752 | 0.230 |
Why?
|
| Silver | 2 | 2014 | 49 | 0.230 |
Why?
|
| Metal Nanoparticles | 2 | 2014 | 88 | 0.210 |
Why?
|
| Chemotaxis | 1 | 2022 | 38 | 0.210 |
Why?
|
| Amino Acid Sequence | 2 | 2020 | 1082 | 0.210 |
Why?
|
| Binding Sites | 4 | 2020 | 631 | 0.210 |
Why?
|
| Dextrans | 2 | 2012 | 33 | 0.210 |
Why?
|
| Fetal Proteins | 1 | 2021 | 4 | 0.210 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 11 | 0.210 |
Why?
|
| 14-3-3 Proteins | 1 | 2021 | 12 | 0.210 |
Why?
|
| Miniaturization | 1 | 2021 | 21 | 0.210 |
Why?
|
| Microfluidics | 1 | 2021 | 22 | 0.200 |
Why?
|
| Printing, Three-Dimensional | 1 | 2021 | 31 | 0.200 |
Why?
|
| Symbiosis | 1 | 2021 | 19 | 0.200 |
Why?
|
| Candida albicans | 1 | 2021 | 38 | 0.200 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 37 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 29 | 0.200 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 69 | 0.200 |
Why?
|
| Models, Immunological | 1 | 2021 | 25 | 0.200 |
Why?
|
| CD4 Antigens | 1 | 2021 | 42 | 0.190 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2021 | 41 | 0.190 |
Why?
|
| Ubiquitin | 1 | 2021 | 74 | 0.190 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 195 | 0.190 |
Why?
|
| Lymphocytes | 1 | 2021 | 228 | 0.190 |
Why?
|
| Pulmonary Fibrosis | 1 | 2022 | 157 | 0.190 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 1849 | 0.180 |
Why?
|
| Spores, Bacterial | 3 | 2009 | 17 | 0.180 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2077 | 0.180 |
Why?
|
| Time-Lapse Imaging | 1 | 2019 | 8 | 0.170 |
Why?
|
| Fluorescein | 1 | 2019 | 15 | 0.170 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 397 | 0.170 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 35 | 0.170 |
Why?
|
| Cell Survival | 2 | 2012 | 901 | 0.170 |
Why?
|
| Extracellular Matrix | 1 | 2022 | 493 | 0.160 |
Why?
|
| Biological Transport | 1 | 2018 | 210 | 0.160 |
Why?
|
| Sodium Azide | 1 | 2017 | 4 | 0.150 |
Why?
|
| Digitonin | 1 | 2017 | 5 | 0.150 |
Why?
|
| Deoxyglucose | 1 | 2017 | 32 | 0.150 |
Why?
|
| Amiloride | 1 | 2017 | 22 | 0.150 |
Why?
|
| Drug Discovery | 1 | 2018 | 94 | 0.150 |
Why?
|
| Proline | 1 | 2017 | 52 | 0.150 |
Why?
|
| Cell Movement | 1 | 2020 | 630 | 0.150 |
Why?
|
| Magnesium | 1 | 2017 | 110 | 0.150 |
Why?
|
| Potassium | 1 | 2017 | 168 | 0.150 |
Why?
|
| Immobilized Proteins | 2 | 2014 | 5 | 0.140 |
Why?
|
| Bacillus subtilis | 2 | 2006 | 49 | 0.140 |
Why?
|
| Surface Plasmon Resonance | 2 | 2014 | 50 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 314 | 0.130 |
Why?
|
| Homeostasis | 1 | 2017 | 291 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2021 | 2688 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1745 | 0.120 |
Why?
|
| Crystallization | 2 | 2010 | 57 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2013 | 1341 | 0.120 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 659 | 0.120 |
Why?
|
| Microscopy, Atomic Force | 2 | 2010 | 66 | 0.120 |
Why?
|
| Particle Size | 2 | 2010 | 201 | 0.110 |
Why?
|
| Subcellular Fractions | 1 | 2013 | 92 | 0.110 |
Why?
|
| Cricetulus | 2 | 2011 | 98 | 0.110 |
Why?
|
| Pinocytosis | 1 | 2012 | 2 | 0.110 |
Why?
|
| CHO Cells | 2 | 2011 | 161 | 0.110 |
Why?
|
| Cricetinae | 2 | 2011 | 262 | 0.110 |
Why?
|
| Protective Agents | 1 | 2013 | 36 | 0.110 |
Why?
|
| Benzoates | 1 | 2012 | 20 | 0.110 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 73 | 0.110 |
Why?
|
| Tannins | 1 | 2012 | 17 | 0.110 |
Why?
|
| Silicon Dioxide | 1 | 2012 | 61 | 0.110 |
Why?
|
| Sulfhydryl Compounds | 1 | 2012 | 73 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 2790 | 0.100 |
Why?
|
| Cisplatin | 1 | 2012 | 192 | 0.100 |
Why?
|
| Deuterium Oxide | 1 | 2011 | 6 | 0.100 |
Why?
|
| Cell Tracking | 1 | 2010 | 3 | 0.100 |
Why?
|
| Chemical Precipitation | 1 | 2010 | 14 | 0.100 |
Why?
|
| Hexokinase | 1 | 2010 | 3 | 0.100 |
Why?
|
| Thermodynamics | 2 | 2017 | 162 | 0.100 |
Why?
|
| Salts | 1 | 2011 | 21 | 0.100 |
Why?
|
| Quercetin | 1 | 2010 | 16 | 0.100 |
Why?
|
| Cell Membrane Permeability | 1 | 2011 | 59 | 0.100 |
Why?
|
| Escherichia coli | 2 | 2010 | 368 | 0.090 |
Why?
|
| Chromatography | 1 | 2010 | 47 | 0.090 |
Why?
|
| Anion Exchange Resins | 1 | 2010 | 13 | 0.090 |
Why?
|
| Bacillus | 1 | 2009 | 5 | 0.090 |
Why?
|
| Escherichia coli Proteins | 1 | 2010 | 64 | 0.090 |
Why?
|
| Carbohydrates | 1 | 2009 | 57 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 189 | 0.090 |
Why?
|
| Nanotubes, Carbon | 1 | 2009 | 73 | 0.090 |
Why?
|
| Nanotechnology | 1 | 2009 | 109 | 0.080 |
Why?
|
| Microfilament Proteins | 3 | 2017 | 102 | 0.080 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2007 | 20 | 0.080 |
Why?
|
| Surface Properties | 3 | 2014 | 363 | 0.070 |
Why?
|
| Picolinic Acids | 1 | 2006 | 4 | 0.070 |
Why?
|
| Oxygen | 1 | 2009 | 386 | 0.070 |
Why?
|
| Vacuoles | 1 | 2006 | 10 | 0.070 |
Why?
|
| Listeria monocytogenes | 1 | 2006 | 15 | 0.070 |
Why?
|
| Humans | 9 | 2022 | 68525 | 0.070 |
Why?
|
| Protein Structure, Quaternary | 1 | 2006 | 31 | 0.070 |
Why?
|
| Intracellular Membranes | 1 | 2006 | 86 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2005 | 1446 | 0.070 |
Why?
|
| Acids | 1 | 2004 | 12 | 0.060 |
Why?
|
| Protein Denaturation | 1 | 2004 | 27 | 0.060 |
Why?
|
| Protein Conformation | 3 | 2017 | 362 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2005 | 144 | 0.060 |
Why?
|
| Complex Mixtures | 1 | 2004 | 14 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 230 | 0.060 |
Why?
|
| Time Factors | 1 | 2012 | 4655 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2005 | 523 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 2 | 2019 | 164 | 0.060 |
Why?
|
| Energy Transfer | 1 | 2002 | 25 | 0.060 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 57 | 0.060 |
Why?
|
| Ammonium Chloride | 1 | 2002 | 4 | 0.050 |
Why?
|
| Organoids | 1 | 2022 | 42 | 0.050 |
Why?
|
| Phospholipase C gamma | 1 | 2021 | 13 | 0.050 |
Why?
|
| Membranes | 1 | 2021 | 26 | 0.050 |
Why?
|
| STAT5 Transcription Factor | 1 | 2021 | 18 | 0.050 |
Why?
|
| Fungal Vaccines | 1 | 2021 | 1 | 0.050 |
Why?
|
| Hyphae | 1 | 2021 | 4 | 0.050 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 50 | 0.050 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2021 | 37 | 0.050 |
Why?
|
| A549 Cells | 1 | 2021 | 50 | 0.050 |
Why?
|
| Antigens, Fungal | 1 | 2021 | 19 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2002 | 155 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 86 | 0.050 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2021 | 3 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2021 | 132 | 0.050 |
Why?
|
| Hybridomas | 1 | 2021 | 25 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2022 | 146 | 0.050 |
Why?
|
| Yeasts | 1 | 2021 | 15 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 79 | 0.050 |
Why?
|
| Pressure | 1 | 2021 | 252 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2021 | 81 | 0.050 |
Why?
|
| Ligands | 1 | 2022 | 317 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2021 | 77 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2002 | 244 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 304 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2021 | 326 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 132 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2021 | 133 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2021 | 178 | 0.050 |
Why?
|
| Colitis | 1 | 2021 | 156 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 131 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 3 | 2005 | 322 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 714 | 0.040 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 121 | 0.040 |
Why?
|
| Mannose | 1 | 2019 | 9 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 331 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 420 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1032 | 0.040 |
Why?
|
| Interferometry | 1 | 2017 | 6 | 0.040 |
Why?
|
| Macromolecular Substances | 2 | 2009 | 122 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2009 | 79 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 756 | 0.040 |
Why?
|
| Diagnostic Imaging | 2 | 2009 | 201 | 0.040 |
Why?
|
| Lung | 1 | 2022 | 849 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2022 | 902 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2017 | 107 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 2 | 2008 | 200 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 1026 | 0.030 |
Why?
|
| Protein Structure, Secondary | 2 | 2005 | 136 | 0.030 |
Why?
|
| Antibodies, Immobilized | 1 | 2014 | 2 | 0.030 |
Why?
|
| Avidin | 1 | 2014 | 6 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 2014 | 30 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2014 | 112 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1070 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 381 | 0.030 |
Why?
|
| Light | 1 | 2014 | 152 | 0.030 |
Why?
|
| Antibodies | 1 | 2014 | 241 | 0.030 |
Why?
|
| Serum Albumin, Bovine | 1 | 2012 | 43 | 0.030 |
Why?
|
| Gold | 1 | 2012 | 76 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4843 | 0.030 |
Why?
|
| Cattle | 1 | 2012 | 475 | 0.030 |
Why?
|
| Mutation | 2 | 2007 | 1213 | 0.020 |
Why?
|
| Flavonoids | 1 | 2010 | 109 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 5708 | 0.020 |
Why?
|
| Membranes, Artificial | 1 | 2010 | 88 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2009 | 128 | 0.020 |
Why?
|
| Adsorption | 1 | 2010 | 225 | 0.020 |
Why?
|
| Female | 2 | 2021 | 38015 | 0.020 |
Why?
|
| Porphyrins | 1 | 2009 | 15 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 508 | 0.020 |
Why?
|
| Platinum | 1 | 2009 | 17 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 742 | 0.020 |
Why?
|
| Materials Testing | 1 | 2009 | 263 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 8903 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 1173 | 0.020 |
Why?
|
| Corneal Neovascularization | 1 | 2007 | 6 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 40 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2007 | 48 | 0.020 |
Why?
|
| Cornea | 1 | 2007 | 76 | 0.020 |
Why?
|
| Membrane Fusion | 1 | 2006 | 7 | 0.020 |
Why?
|
| Hemolysin Proteins | 1 | 2006 | 9 | 0.020 |
Why?
|
| Microscopy | 1 | 2006 | 64 | 0.020 |
Why?
|
| Endospore-Forming Bacteria | 1 | 2006 | 2 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 219 | 0.020 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2006 | 7 | 0.020 |
Why?
|
| Alanine | 1 | 2006 | 38 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2006 | 69 | 0.020 |
Why?
|
| Permeability | 1 | 2006 | 131 | 0.020 |
Why?
|
| 4-Chloro-7-nitrobenzofurazan | 1 | 2005 | 1 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2005 | 63 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2005 | 24 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 14842 | 0.020 |
Why?
|
| Guanidine | 1 | 2004 | 7 | 0.020 |
Why?
|
| Cysteine | 1 | 2005 | 112 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2004 | 99 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 337 | 0.020 |
Why?
|
| Temperature | 1 | 2006 | 340 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2004 | 99 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 21119 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 21375 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 2002 | 169 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 1015 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2004 | 546 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 376 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 981 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 2673 | 0.010 |
Why?
|
| Male | 1 | 2021 | 37281 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2002 | 705 | 0.010 |
Why?
|